MA03.01 EPICAL Trial. A Phase Ib StudyCombining Anti-Epidermal Growth Factor (EGF) Vaccination With Afatinib in EGFR-Mutant Non-Small Cell Lung Cancer
Keyword(s):
Phase Ib
◽
Keyword(s):
2017 ◽
Vol 31
(1)
◽
pp. 83-99
◽
2011 ◽
Vol 113
(6)
◽
pp. 1353-1364
◽
Keyword(s):